Last Updated: Jan 15 2009 - Able2Act

Fact Sheet for Purdue Pharma L.P.

Country: USA
Contact: Purdue Pharma L.P.One Stamford ForumStamford, CT 06901 United States
Comments: Purdue Pharma offers Cost-free training and educational materials regarding prescription drug abuse and diversion.
Compilation by Silobreaker
Although Silobreaker has relied on what it regards as reliable sources while compiling the content herein, Silobreaker cannot guarantee the accuracy, completeness, integrity or quality of such content and no responsibility is accepted by Silobreaker in respect of such content. Readers must determine for themselves what reliance they should place on the compiled content herein.

Related Stories

First reported 14 hours ago - Updated 3 hours ago - 2 reports

Oxycontin marketing suit is Purdue Pharma’s ‘legal nightmare’

Trials & LitigationPosted Oct 22, 2014 05:45 am CDTBy A civil lawsuit filed by the state of Kentucky against the maker of Oxycontin could tarnish the company’s mostly successful legal track record in cases alleging abuse of the painkiller.Purdue Pharma ... [Published ABA Journal - 3 hours ago]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Five things for pharma marketers to know: Monday, October 20, 2014

Share this article: In a civil suit levied by the state of Kentucky, Purdue Pharma has been accused of facilitating prescription opioid addiction on a grand scale. The state further alleges that Purdue trained its sales representatives to mislead doctors ... [Published Medical Marketing And Media - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Purdue Pharma Launches Awareness Campaign to Inform Pharmacists of a CIII Extended-Release Opioid

Purdue is at the forefront of medical advances and provides timely news updates about its family of products, resources, and events.Triggered by low awareness revealed by Harris Poll, webcast, printed downloadable materials aim toimprove pharmacists' ... [Published Noodls - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Addiction-riddled Kentucky out for blood in $1B suit against OxyContin-maker Purdue

To settle or not to settle? That's always the question in drugmaker lawsuits, but Purdue Pharma faces a more dramatic choice than most in a Kentucky lawsuit. As Bloomberg reports, the state accuses the OxyContin maker of Medicaid fraud, false advertising, ... [Published FiercePharma - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Frank Iannarone Receives 2014 NCPA Prescription Drug Safety Award

PRESS RELEASEAustin, Texas (October 20, 2014) – Frank Iannarone III, RPh, owner of Madison Pharmacy in Madison, N.J., was named the winner of the 2014 NCPA Prescription Drug Safety Award. Sponsored by Purdue Pharma, L.P ., the award recognizes pharmacists ... [Published Pharmacy Times - Oct 20 2014]
First reported Oct 18 2014 - Updated Oct 18 2014 - 1 reports

Purdue Pharma launches pharmacist awareness campaign around Butrans

STAMFORD, Conn. — A recent survey indicates that pharmacists in the United States wish they had better resource materials to help them counsel patients about prescription opioid medications. To help meet this need, Purdue Pharma has launched an awareness ... [Published Drug Store News - Oct 18 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Canadian pills allegedly travel long-distance

By Alexander Panetta, The Canadian PressWASHINGTON - The ongoing availability in Canada of an abuse-prone pharmaceutical may be having a spillover effect far beyond its borders.A form of OxyContin that was banned in the United States last year is still ... [Published Kelowna Capital - Oct 16 2014]
Entities: Opioid, OxyContin, Overdose
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Mealey's PI/Product Liability - Judge Won't Block USA Today's Public Record Request For Presuit Subpoena Material

CHICAGO - An Illinois federal judge on Oct. 10 refused to stop USA Today from seeking subpoenaed documents produced by Janssen Pharmaceuticals Inc. and Cephalon Inc. because the requested information predated the filing of Chicago's opioid marketing lawsuit ... [Published Mealey - Oct 15 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Purdue Pharma launches new dosage strength of Butrans Transdermal System CIII

Purdue Pharma L.P., a developer of prescription and over-the-counter medicines, has launched the new 7.5mcg/hour dosage strength of Butrans Transdermal System CIII, which is indicated for management of pain in the US. Five strengths of Butrans are now ... [Published - Oct 13 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 5 reports

Purdue Pharma launches new dosage of Butrans

STAMFORD, Conn. — Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.Butrans — a schedule ... [Published Drug Store News - Oct 09 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

Purdue Pharma Lecture brings leading blood cancer expert to UOIT - October 06, 2014

There is ample reason for optimism in the battle against blood cancer, says one of Canada's leading authorities on leukemia, drug recycling and molecular genetics.Dr. Aaron Schimmer came to the University of Ontario Institute of Technology (UOIT) on September ... [Published Noodls - Oct 06 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Actavis confirms patent challenge for generic Butrans

DUBLIN — Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma. The drug is used for the treatment ... [Published Drug Store News - Sep 26 2014]
In Focus


sort by: Date | Relevance
Purdue Pharma L.P. Names Susie Robinson Vice Pr... [Published PR Newswire: Financial Services - Sep 15 2014]
STAMFORD, Conn., Sept. 15, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Susie Robinson, former head of human resources at Lumeris, has joined the company as Vice President of Human Resources. "With her proven record of transforming ...
Purdue Pharma L.P. Names Saeed Motahari Senior ... [Published PR Newswire: Health - May 22 2014]
STAMFORD, Conn., May 22, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Saeed Motahari has joined the company as Senior Vice President and Chief Commercial Officer."We welcome Saeed to the Purdue team. I am confident that his impressive ...
Purdue Pharma L.P. Presents Data from Research ... [Published PR Newswire: General Business - Apr 29 2014]
STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33rd Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla.Following is a schedule of ...
MS CONTIN (Morphine Sulfate) Tablet, Film Coate... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
Updated Date: Jun 19, 2014 EST ...
Purdue Pharma L.P. Submits NDA for Once-Daily H... [Published PR Newswire: General Business - Apr 30 2014]
STAMFORD, Conn., April 30, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) seeking authorization to market a once-daily, single-entity hydrocodone bitartrate ...
1 2 3

Press Releases

sort by: Date | Relevance
Purdue Pharma L.P., a Leading Pharmaceutical Co... [Published Financial Services - Jun 18 2014]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.